INSTRUMENT FOR REAL TIME RENAL MONITORING

Information

  • Research Project
  • 2770450
  • ApplicationId
    2770450
  • Core Project Number
    R44DK047761
  • Full Project Number
    5R44DK047761-03
  • Serial Number
    47761
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1994 - 30 years ago
  • Project End Date
    7/1/2000 - 24 years ago
  • Program Officer Name
    SCHERBENSKE, M. JAMES
  • Budget Start Date
    9/1/1998 - 26 years ago
  • Budget End Date
    7/1/2000 - 24 years ago
  • Fiscal Year
    1998
  • Support Year
    3
  • Suffix
  • Award Notice Date
    1/11/2001 - 23 years ago
Organizations

INSTRUMENT FOR REAL TIME RENAL MONITORING

The mortality rate for acute renal failure has not changed significantly during the last 25 years. This may be due in part, to the inability to adequately predict and identify the onset and causes of acute renal failure. Current measurement techniques cannot quickly identify changes in renal function; the time for measuring renal function is typically four hours. An accurate means for measuring renal function in real time (i.e.,measuring and seeing changes in renal function as they occur) should allow researchers to better understand the pathophysiology of acute renal failure and lead to significant reductions in mortality rate and in the number of persons requiring acute dialysis associated with acute renal failure. The goal of this proposal is: 1) to complete development of an instrument for measuring renal function in real time and 2) to validate the measurement accuracy and the response time for rapid changes in renal function. Making this instrument available to nephrologists should allow researchers to demonstrate the efficacy of real time renal monitoring in saving lives and reducing the number of those who require acute dialysis. This may lead to real-time renal monitoring of most intensive care and organ transplant patient. PROPOSED COMMERCIAL APPLICATION: The commercial motivation for this project is two fold. 1) the cost benefit to patients and healthcare providers derived from less time in Icu and from reducing the number of persons permanently needing dialysis and 2) commercial sales of renal monitors for use in ICU' s worldwide. Annual commercial sales should exceed $10 million, and savings in healthcare costs should be even greater.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    DIGIRAD CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921213415
  • Organization District
    UNITED STATES